Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$703M |
| 2 |
Tesla
TSLA
|
+$585M |
| 3 |
JPMorgan Chase
JPM
|
+$582M |
| 4 |
Amazon
AMZN
|
+$566M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$466M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$349M |
| 2 |
Home Depot
HD
|
+$334M |
| 3 |
T-Mobile US
TMUS
|
+$270M |
| 4 |
Cigna
CI
|
+$258M |
| 5 |
CDW
CDW
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 83.85% |
| 2 | Technology | 3.12% |
| 3 | Healthcare | 2.55% |
| 4 | Financials | 2.39% |
| 5 | Consumer Discretionary | 2.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
6426
CALL
Advanced Drainage Systems
WMS
$9.6B
| $1.26M | ﹤0.01% |
10,100
-1,800
| -15% | -$224K |
2020 Q2
9 quarters
|
|
|
DCBO
6427
Docebo
DCBO
$582M
| $1.25M | ﹤0.01% |
46,479
-2,210
| -5% | -$67.3K |
2021 Q1
6 quarters
|
|
6428
CALL
Playtika
PLTK
$831M
| $1.25M | ﹤0.01% |
133,600
-199,600
| -60% | -$2.3M |
2021 Q1
6 quarters
|
|
|
BHVN
6429
CALL
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $1.25M | ﹤0.01% |
8,300
-15,300
| -65% | -$2.27M |
2018 Q4
15 quarters
|
|
|
FOCL
6430
EDAP TMS S.A.
FOCL
$198M
| $1.25M | ﹤0.01% |
151,906
+122,208
| +412% | +$930K |
2022 Q2
1 quarter
|
|
6431
UBS Group
UBS
$146B
| $1.25M | ﹤0.01% |
86,361
+60,061
| +228% | +$962K |
2021 Q4
3 quarters
|
|
6432
PUT
Brookfield Renewable
BEP
$8.51B
| $1.25M | ﹤0.01% |
40,000
+12,000
| +43% | +$444K |
2021 Q1
6 quarters
|
|
6433
PUT
Thomson Reuters
TRI
$42.3B
| $1.25M | ﹤0.01% |
11,579
+5,410
| +88% | +$627K |
2019 Q2
13 quarters
|
|
6434
PUT
Woodside Energy
WDS
$41.4B
| $1.25M | ﹤0.01% |
62,104
-23,584
| -28% | -$520K |
2022 Q2
1 quarter
|
|
6435
Invesco Building & Construction ETF
PKB
$287M
| $1.25M | ﹤0.01% |
33,661
+20,859
| +163% | +$845K |
2021 Q2
5 quarters
|
|
6436
Victory Portfolios II VictoryShares Core Intermediate Bond ETF
UITB
$2.61B
| $1.25M | ﹤0.01% |
27,798
-8,311
| -23% | -$391K |
2021 Q3
4 quarters
|
|
|
RPTX
6437
CALL
DELISTED
Repare Therapeutics
RPTX
| $1.25M | ﹤0.01% |
103,000
-6,200
| -6% | -$79.8K |
2021 Q2
5 quarters
|
|
6438
CVR Partners
UAN
$1.32B
| $1.25M | ﹤0.01% |
10,914
-32,737
| -75% | -$3.74M |
2021 Q1
6 quarters
|
|
6439
CALL
Dorman Products
DORM
$3.65B
| $1.25M | ﹤0.01% |
15,200
-4,800
| -24% | -$473K |
2018 Q4
15 quarters
|
|
|
VLDR
6440
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
| $1.25M | ﹤0.01% |
1,316,085
-445,678
| -25% | -$521K |
2021 Q2
5 quarters
|
|
6441
Autodesk
ADSK
$44.3B
| $1.25M | ﹤0.01% |
6,663
-216,411
| -97% | -$43.7M |
2016 Q3
24 quarters
|
|
6442
CALL
Triumph Financial Inc
TFIN
$1.49B
| $1.25M | ﹤0.01% |
22,900
+5,600
| +32% | +$368K |
2021 Q1
6 quarters
|
|
|
LONA
6443
CALL
LeonaBio Inc
LONA
$45.4M
| $1.24M | ﹤0.01% |
41,890
-31,340
| -43% | -$1.08M |
2021 Q2
5 quarters
|
|
|
KZR
6444
CALL
DELISTED
Kezar Life Sciences
KZR
| $1.24M | ﹤0.01% |
14,450
-8,280
| -36% | -$804K |
2021 Q4
3 quarters
|
|
6445
CALL
Travere Therapeutics
TVTX
$5.37B
| $1.24M | ﹤0.01% |
50,500
+37,600
| +291% | +$971K |
2021 Q1
6 quarters
|
|
6446
Angi Inc
ANGI
$245M
| $1.24M | ﹤0.01% |
42,086
-94,142
| -69% | -$4.15M |
2020 Q2
9 quarters
|
|
|
BGFV
6447
DELISTED
Big 5 Sporting Goods
BGFV
| $1.24M | ﹤0.01% |
+115,700
| New | +$1.4M |
2022 Q3
0 quarters
|
|
|
CMRC
6448
PUT
Commerce.com Inc Series 1
CMRC
$269M
| $1.24M | ﹤0.01% |
83,900
-24,700
| -23% | -$424K |
2020 Q3
8 quarters
|
|
6449
CALL
Kodak
KODK
$960M
| $1.24M | ﹤0.01% |
270,600
+147,100
| +119% | +$803K |
2020 Q3
8 quarters
|
|
6450
Xtrackers Russell US Multifactor ETF
DEUS
$288M
| $1.24M | ﹤0.01% |
32,804
+23,348
| +247% | +$970K |
2021 Q4
3 quarters
|
|
Similar funds
Citadel Advisors's Q3 2022 Portfolio in Review
As of Q3 2022, Citadel Advisors held 14,356 positions worth $439B, up 13% from $390B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Citadel Advisors's Q3 2022 filing shows 1,622 new, 5,458 increased, 5,221 reduced and 1,857 closed positions. Its largest new stake was SentinelOne: 4,426,634 shares worth $113M. The largest sale was Meta Platforms (Facebook), an estimated $349M.
By sector, the portfolio is most concentrated in Miscellaneous at 84% of assets, down from 84% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q3 2022 buy was SentinelOne: 4,426,634 shares worth $113M.
- Citadel Advisors added most to Apple in Q3 2022, an estimated $703M increase.
- Citadel Advisors's biggest Q3 2022 reduction was Meta Platforms (Facebook), cutting an estimated $349M.
- Citadel Advisors fully exited Regions Financial in Q3 2022, selling an estimated $207M.
- Citadel Advisors's ten largest holdings make up 34% of its $439B portfolio in Q3 2022.
- Citadel Advisors opened 1,622 new positions and closed 1,857 in Q3 2022.
- Citadel Advisors's portfolio value rose 13% quarter-over-quarter to $439B.
Based on Citadel Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.